Latest news from our partners

Syndicate content

HIV-specialists in high demand in Zambia

In a country struggling with an extreme HIV epidemic, the University of Zambia is educating neuropsychologists to deal with the huge demand for professionals.

Testing nasal vaccine for HIV treatment

Researchers are working to find out whether a HIV vaccine developed by a Norwegian biotech company can be administered nasally.

Better prepared for E. coli outbreaks

New methods speed up the process of identifying E. coli bacteria that make people sick. Swift identification may spare lives.

Foreign investors stimulate the Norwegian economy

Foreign investors provides Norwegian listed companies with access to cheaper capital, according to new study.

Smarter prostheses using iPhone technology

Simple, cheap microtechnology paves the way for a new generation of prostheses.

Religious beliefs battle hypertension

Churchgoers have lower blood pressure. So is it healthy to believe in God?

Virus makes good E. coli bad

Some E. coli bacteria are harmless and some are dangerous from the outset. Then some become dangerous when they meet viruses. Scientists search for tools that will reduce this risk.

How much food do seabirds need?

Many seabirds begin to suffer when the food available for them in the ocean declines below a critical level. This level is about one-third of the maximum amount of food available.

The missionary was meek before God and mighty before men

In the 1800s, Norwegian missionaries had to strike a difficult balance between Christian virtues and the new man’s role.

From poison to palatable

Every night millions of people go to bed hungry. New genetic technology can help us feed the world by making inedible seeds more edible.
Syndicate content